DTL
OREX

Dynamic Technology Lab’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Dynamic Technology Lab’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,738
Closed -$105K – 1086
2014
Q4 		$105K Buy
+1,738
New +$87.3K 0.05% 574
2013
Q4 		– Sell
-2,566
Closed -$158K – 828
2013
Q3 		$158K Buy
+2,566
New +$174K 0.13% 375

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dynamic Technology Lab's OREX Position: Q1 2015 in Review

Dynamic Technology Lab sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2015, closing a stake of 1,738 shares — an estimated $105K sold.

Dynamic Technology Lab first reported a position in OREX in Q3 2013 and held it in 2 quarters. The position peaked at $158K in Q3 2013. 160 funds tracked by Wall St. Rank hold OREX as of Q1 2015.

  • Dynamic Technology Lab reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,738 Orexigen Therapeutics, Inc. shares in Q1 2015, an estimated $105K.
  • Dynamic Technology Lab first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and held it in 2 quarters.
  • Dynamic Technology Lab's Orexigen Therapeutics, Inc. position peaked at $158K in Q3 2013.
  • 160 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2015.

Based on Dynamic Technology Lab's 13F filing for Q1 2015, filed 12 May 2015.